Technical Analysis for ALDX - Aldeyra Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 7.45 -5.82% -0.46
ALDX closed down 5.82 percent on Friday, March 22, 2019, on 1.72 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALDX trend table...

Date Alert Name Type % Chg
Mar 22 MACD Bearish Centerline Cross Bearish 0.00%
Mar 22 MACD Bearish Signal Line Cross Bearish 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 21 Fell Below 20 DMA Bearish -5.82%
Mar 21 Outside Day Range Expansion -5.82%
Mar 20 20 DMA Support Bullish -8.81%
Mar 20 NR7 Range Contraction -8.81%
Mar 20 NR7-2 Range Contraction -8.81%
Mar 19 50 DMA Resistance Bearish -10.56%

Older signals for ALDX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aldeyra Therapeutics, Inc. (Aldeyra) is a biotechnology company. The Company is focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The Company is developing NS2. NS2 is a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of diseases, which include Sjogren-Larsson Syndrome (SLS), discoid lupus, acute anterior uveitis and ocular rosacea with meibomian gland dysfunction. Aldeyra is also developing aldehyde traps distinct from NS2. As of April 7, 2014, it had evaluated NS2 in a Phase I clinical trial in 48 volunteers.
Medicine Biotechnology Medical Specialties Diseases Organ Systems Autoimmune Diseases Rare Diseases Uveitis Inflammatory Syndromes
Is ALDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.7
52 Week Low 6.75
Average Volume 246,768
200-Day Moving Average 8.9111
50-Day Moving Average 8.3458
20-Day Moving Average 8.1015
10-Day Moving Average 8.351
Average True Range 0.5979
ADX 14.49
+DI 19.2192
-DI 29.0032
Chandelier Exit (Long, 3 ATRs ) 7.7163
Chandelier Exit (Short, 3 ATRs ) 8.8437
Upper Bollinger Band 9.0632
Lower Bollinger Band 7.1398
Percent B (%b) 0.16
BandWidth 23.741282
MACD Line -0.0597
MACD Signal Line -0.0171
MACD Histogram -0.0425
Fundamentals Value
Market Cap 46.53 Million
Num Shares 6.25 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -5.07
Price-to-Sales 0.00
Price-to-Book 4.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.80
Resistance 3 (R3) 8.82 8.38 8.58
Resistance 2 (R2) 8.38 8.04 8.38 8.50
Resistance 1 (R1) 7.92 7.83 7.70 7.90 8.43
Pivot Point 7.48 7.48 7.38 7.48 7.48
Support 1 (S1) 7.02 7.14 6.80 7.00 6.47
Support 2 (S2) 6.58 6.93 6.57 6.40
Support 3 (S3) 6.12 6.58 6.32
Support 4 (S4) 6.10